ArticleJCO global oncology2021

Real-World Data (RWD) on the 3-Year Follow-Up Outcomes of Different CNS Prophylaxis Strategies Across CNS-IPI Risk Groups in Patients With Diffuse Large B-Cell Non-Hodgkin Lymphoma.

Anadil Faqah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.